313 related articles for article (PubMed ID: 21209282)
1. Invariant NKT cells inhibit autoreactive B cells in a contact- and CD1d-dependent manner.
Yang JQ; Wen X; Kim PJ; Singh RR
J Immunol; 2011 Feb; 186(3):1512-20. PubMed ID: 21209282
[TBL] [Abstract][Full Text] [Related]
2. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.
Wermeling F; Lind SM; Jordö ED; Cardell SL; Karlsson MC
J Exp Med; 2010 May; 207(5):943-52. PubMed ID: 20439539
[TBL] [Abstract][Full Text] [Related]
3. Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.
Yang JQ; Kim PJ; Singh RR
J Clin Immunol; 2012 Feb; 32(1):106-13. PubMed ID: 22002593
[TBL] [Abstract][Full Text] [Related]
4. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
Shen L; Zhang H; Caimol M; Benike CJ; Chakravarty EF; Strober S; Engleman EG
Eur J Immunol; 2015 Feb; 45(2):612-23. PubMed ID: 25352488
[TBL] [Abstract][Full Text] [Related]
5. Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice.
Forestier C; Molano A; Im JS; Dutronc Y; Diamond B; Davidson A; Illarionov PA; Besra GS; Porcelli SA
J Immunol; 2005 Jul; 175(2):763-70. PubMed ID: 16002672
[TBL] [Abstract][Full Text] [Related]
6. Homeostatic regulation of marginal zone B cells by invariant natural killer T cells.
Wen X; Yang JQ; Kim PJ; Singh RR
PLoS One; 2011; 6(10):e26536. PubMed ID: 22046304
[TBL] [Abstract][Full Text] [Related]
7. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
[TBL] [Abstract][Full Text] [Related]
8. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.
Lombardi V; Stock P; Singh AK; Kerzerho J; Yang W; Sullivan BA; Li X; Shiratsuchi T; Hnatiuk NE; Howell AR; Yu KO; Porcelli SA; Tsuji M; Kronenberg M; Wilson SB; Akbari O
J Immunol; 2010 Feb; 184(4):2107-15. PubMed ID: 20083656
[TBL] [Abstract][Full Text] [Related]
9. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
10. Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.
Tang X; Zhang B; Jarrell JA; Price JV; Dai H; Utz PJ; Strober S
J Autoimmun; 2014 May; 50():87-98. PubMed ID: 24508410
[TBL] [Abstract][Full Text] [Related]
11. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
[TBL] [Abstract][Full Text] [Related]
12. JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.
Liu J; Gallo RM; Khan MA; Iyer AK; Kratzke IM; Brutkiewicz RR
Eur J Immunol; 2019 Feb; 49(2):255-265. PubMed ID: 30467836
[TBL] [Abstract][Full Text] [Related]
13. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
[TBL] [Abstract][Full Text] [Related]
14. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
[TBL] [Abstract][Full Text] [Related]
15. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.
Olson CM; Bates TC; Izadi H; Radolf JD; Huber SA; Boyson JE; Anguita J
J Immunol; 2009 Mar; 182(6):3728-34. PubMed ID: 19265151
[TBL] [Abstract][Full Text] [Related]
16. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis.
Yang JQ; Singh AK; Wilson MT; Satoh M; Stanic AK; Park JJ; Hong S; Gadola SD; Mizutani A; Kakumanu SR; Reeves WH; Cerundolo V; Joyce S; Van Kaer L; Singh RR
J Immunol; 2003 Aug; 171(4):2142-53. PubMed ID: 12902521
[TBL] [Abstract][Full Text] [Related]
18. CD252 regulates mast cell mediated, CD1d-restricted NKT-cell activation in mice.
Gonzalez Roldan N; Orinska Z; Ewers H; Bulfone-Paus S
Eur J Immunol; 2016 Feb; 46(2):432-9. PubMed ID: 26564814
[TBL] [Abstract][Full Text] [Related]
19. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
[TBL] [Abstract][Full Text] [Related]
20. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells.
Abós-Gracia B; del Moral MG; López-Relaño J; Viana-Huete V; Castro L; Villalba M; Martínez-Naves E
J Allergy Clin Immunol; 2013 May; 131(5):1393-9.e5. PubMed ID: 23265858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]